Interface Selection for Adaptive Servo Ventilation: A Randomized Controlled Study
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Enrollment
- 15
- Locations
- 2
- Primary Endpoint
- Apnea/hypopnea index
Study Overview
Brief Summary
The purpose of this study is to compare the effects of nasal and oronasal interfaces during ASV treatment on sleep efficiency and sleep architecture. Therefore, patients starting treatment with ASV, will be randomized between two groups. In the first group, patients will use a nasal interface during the first night and an oronasal interface during the second night. In the second group, patients will use an oronasal mask first and a nasal mask during the second night. The results of this trial will have major impact on future clinical practice as it would deliver prediction rules to choose the correct interface immediately.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Crossover
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients with central sleep apnea, not responding to treatment with CPAP
- •Indication for treatment with ASV
Exclusion Criteria
- •Patients < 18 years old
Outcomes
Primary Outcomes
Apnea/hypopnea index
Time Frame: Two nights
Effect on respiratory events
Secondary Outcomes
- Sleep architecture(Two nights)
- Mask comfort VAS(Two nights)
- Device leaks data(Two nights)
- Sleep efficiency(Two nights)
